Degludec Insulin Use in Critically Ill Patients
Diabetes Mellitus, Critical Illness, Hyperglycemia
About this trial
This is an interventional treatment trial for Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria: Patients aged 18 years and above Newly admitted critically ill patients with diabetes and expected ICU stay ≥ 48 hours Medical or surgical ICU patients Exclusion Criteria: Patients who were already started on insulin infusion based on physician discretion. Postoperative patients with expected ICU stay less than 48 hours Diabetic ketoacidosis or hyperosmolar hyperglycemic state. Patients with Do-Not-Attempt-Resuscitation (DNAR) status or imminent plan to palliation due to terminal disease. Refusal of the treating physician to enroll the patient into the study. Patients with diabetes mellitus Type 1. Patients who already eating prior to study enrollment
Sites / Locations
- King Faisal Specialist Hospital & Research CentreRecruiting
Arms of the Study
Arm 1
Experimental
Degludec